197 related articles for article (PubMed ID: 29212069)
1. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
Eckert M; Klumpp L; Huber SM
Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
4. BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells.
Edalat L; Stegen B; Klumpp L; Haehl E; Schilbach K; Lukowski R; Kühnle M; Bernhardt G; Buschauer A; Zips D; Ruth P; Huber SM
Oncotarget; 2016 Mar; 7(12):14259-78. PubMed ID: 26893360
[TBL] [Abstract][Full Text] [Related]
5. Molecular dissection of the valproic acid effects on glioma cells.
Hoja S; Schulze M; Rehli M; Proescholdt M; Herold-Mende C; Hau P; Riemenschneider MJ
Oncotarget; 2016 Sep; 7(39):62989-63002. PubMed ID: 27556305
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation.
Van Nifterik KA; Van den Berg J; Slotman BJ; Lafleur MV; Sminia P; Stalpers LJ
J Neurooncol; 2012 Mar; 107(1):61-7. PubMed ID: 22037799
[TBL] [Abstract][Full Text] [Related]
7. TRPM8 is required for survival and radioresistance of glioblastoma cells.
Klumpp D; Frank SC; Klumpp L; Sezgin EC; Eckert M; Edalat L; Bastmeyer M; Zips D; Ruth P; Huber SM
Oncotarget; 2017 Nov; 8(56):95896-95913. PubMed ID: 29221175
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.
Papi A; Ferreri AM; Rocchi P; Guerra F; Orlandi M
Anticancer Res; 2010 Feb; 30(2):535-40. PubMed ID: 20332466
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
[TBL] [Abstract][Full Text] [Related]
12. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.
Hosein AN; Lim YC; Day B; Stringer B; Rose S; Head R; Cosgrove L; Sminia P; Fay M; Martin JH
J Neurooncol; 2015 Apr; 122(2):263-71. PubMed ID: 25648357
[TBL] [Abstract][Full Text] [Related]
13. Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
Wedel S; Hudak L; Seibel JM; Juengel E; Oppermann E; Haferkamp A; Blaheta RA
Prostate; 2011 May; 71(7):722-35. PubMed ID: 20954195
[TBL] [Abstract][Full Text] [Related]
14. Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro.
Knüpfer MM; Pulzer F; Schindler I; Hernaíz Driever P; Knüpfer H; Keller E
Anticancer Res; 2001; 21(1A):347-51. PubMed ID: 11299760
[TBL] [Abstract][Full Text] [Related]
15. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
Krauze AV; Zhao Y; Li MC; Shih J; Jiang W; Tasci E; Cooley Zgela T; Sproull M; Mackey M; Shankavaram U; Tofilon P; Camphausen K
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892181
[TBL] [Abstract][Full Text] [Related]
16. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
Rubner Y; Muth C; Strnad A; Derer A; Sieber R; Buslei R; Frey B; Fietkau R; Gaipl US
Radiat Oncol; 2014 Mar; 9(1):89. PubMed ID: 24678590
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
[TBL] [Abstract][Full Text] [Related]
18. Effect of valproic acid on the outcome of glioblastoma multiforme.
Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
[TBL] [Abstract][Full Text] [Related]
19. Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.
Stegen B; Butz L; Klumpp L; Zips D; Dittmann K; Ruth P; Huber SM
Mol Cancer Res; 2015 Sep; 13(9):1283-95. PubMed ID: 26041939
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.
Vallo S; Xi W; Hudak L; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
Anticancer Drugs; 2011 Nov; 22(10):1002-9. PubMed ID: 21822119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
